Atlas Trials

The Value of Serum MicroRNA-21-5p and LncRNAgadd7 Expression Levels in Predicting the Severity and Prognosis of ARDS ( Acute Respiratory Distress Syndrome )

Clinical trial NCT06825754 · COMPLETED

Trial details

NCT number
NCT06825754
Sponsor
Shao Yuekai
Status
COMPLETED
Study type
OBSERVATIONAL
Acute Respiratory Distress Syndrome
Start date
2023-11-01
Primary completion
2024-11-30
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.